When switching from Ozempic to Mounjaro, you almost always restart titration at the lowest tirzepatide dose of 2.5 mg — your Ozempic milligrams do not carry over. These are two different molecules, dosed on entirely separate scales, so there is no equivalent conversion. Your prescriber decides the timing and the starting point, not a chart on the internet.
That single fact surprises most people. You might be cruising along on 1 mg or 2 mg of Ozempic (semaglutide) and feel ready for "more," only to learn that switching to Mounjaro (tirzepatide) means going back to the bottom of a brand-new ladder. This guide explains why that happens, lays the two titration schedules side by side, and covers what to expect through the change — including how to keep your dose and injection history intact when you move.
Why People Switch From Ozempic to Mounjaro
The two drugs are not the same class of single mechanism. Ozempic is a GLP-1 receptor agonist. Mounjaro is a dual GIP/GLP-1 receptor agonist, meaning it activates a second incretin pathway. Common reasons a prescriber moves someone from semaglutide to tirzepatide include:
- Plateaued results. Weight loss or A1C improvement has stalled on the maximum tolerated Ozempic dose.
- Insurance or supply changes. Coverage, formulary shifts, or shortages push a switch.
- Tolerability. Some people handle one molecule's side effect profile better than the other.
- Clinical fit. A prescriber may judge tirzepatide a better match for a given person's goals.
Head-to-head trial data has shown tirzepatide producing greater average weight loss than semaglutide in adults with obesity, according to the SURMOUNT-5 trial summarized by the NIH, though individual results vary widely and your prescriber's judgment matters more than any average. Whatever your reason, the mechanics of the switch are what trip people up — so let's get specific.
Why You Restart Titration (and Don't Carry Over the mg)
Here is the part to internalize: semaglutide milligrams and tirzepatide milligrams are not interchangeable units. A 2 mg dose of Ozempic is not "the same as" 2.5 mg of Mounjaro. They are different molecules with different potency curves, so there is no clean conversion factor a patient should apply on their own.
Both drugs are titrated deliberately to limit gastrointestinal side effects — nausea, vomiting, diarrhea, constipation — that come from ramping a GLP-1 (or GIP/GLP-1) agonist too fast. The Mounjaro prescribing information from Eli Lilly directs starting at 2.5 mg once weekly for four weeks as a non-therapeutic lead-in dose, then stepping up. When you arrive from Ozempic, your gut is conditioned to semaglutide, not tirzepatide, so the standard guidance is to begin at that 2.5 mg starting dose regardless of how high your Ozempic dose was.
Your prescriber may individualize this. Some clinicians, for a patient who tolerated high-dose semaglutide well, may move through the early tirzepatide steps a bit differently. But that is a clinical decision made by your prescriber — you do not carry your old milligram number across, and you should never self-adjust to "match" your previous dose. Always verify your exact starting dose and schedule with the person who wrote the prescription.
What "restart" actually feels like
Restarting at 2.5 mg does not usually mean losing all your progress. Because tirzepatide is a different and often more potent mechanism, many people continue seeing results even at the low lead-in dose. The first few weeks are about letting your body adjust to the new molecule, not about therapeutic effect. Track how you feel week by week so you and your prescriber have real data for each step-up decision.
Ozempic vs. Mounjaro: The Two Dose Ladders Side by Side
This is the clearest way to see why the switch is a fresh start. Ozempic climbs in four maintenance-relevant steps to a 2 mg ceiling; Mounjaro climbs through six steps to a 15 mg ceiling. The numbers live on different scales entirely.
| Step | Ozempic (semaglutide) | Mounjaro (tirzepatide) | Typical duration per step |
|---|---|---|---|
| 1 (lead-in) | 0.25 mg | 2.5 mg | ~4 weeks |
| 2 | 0.5 mg | 5 mg | ~4 weeks |
| 3 | 1 mg | 7.5 mg | ~4 weeks |
| 4 | 2 mg (max) | 10 mg | ~4 weeks |
| 5 | — | 12.5 mg | ~4 weeks |
| 6 | — | 15 mg (max) | maintenance |
Dose and timing per the Ozempic prescribing information from Novo Nordisk and the Mounjaro prescribing information from Eli Lilly. Both drugs are once-weekly subcutaneous injections, and both lead-in steps (0.25 mg semaglutide, 2.5 mg tirzepatide) are intended to reduce side effects, not to be maintenance doses. Steps usually last about four weeks, but your prescriber sets your pace based on tolerance and response — these durations are typical, not guaranteed.
Notice there is no row where the milligram values align. That visual gap is exactly why "I was on 1 mg, so I'll start at 1 mg" makes no sense across these two medications. For a deeper look at either schedule on its own, see our Ozempic tracker overview and Mounjaro tracker overview.
What to Expect Through the Switch
The first month
Expect a one-to-two week gap, in many cases, between your last Ozempic dose and your first Mounjaro dose — your prescriber will tell you exactly when to take the first 2.5 mg injection. Both are weekly, so you generally pick up the same once-a-week rhythm. Side effects can feel new even if you were a seasoned Ozempic user, because the GIP component changes how appetite and digestion respond.
Injection sites and rotation
Both medications are injected subcutaneously into the abdomen, thigh, or back of the upper arm, and both benefit from rotating sites to avoid irritation and lipohypertrophy. Your rotation routine does not reset just because the drug changed — keep cycling through sites the same way. If you want a refresher on a clean rotation pattern, our GLP-1 injection sites guide walks through it.
Tracking side effects step by step
Because Mounjaro has six steps instead of four, you have more dose changes to log and more chances to correlate a step-up with how you feel. Keeping a simple record of nausea, energy, appetite, and weight at each level gives your prescriber concrete information for the next decision. Our piece on tracking GLP-1 side effects covers a lightweight way to do this.
Keep Your History When You Switch Medications
A medication change is exactly when tracking continuity matters most — and exactly when most people lose it. If your data lived in a spreadsheet or scattered notes, switching drugs is where the thread usually breaks.
In OffGrid Dose, changing your active medication does not erase anything. You switch from Ozempic to Mounjaro inside the app, and the new tirzepatide titration ladder loads automatically while your prior injection log, site-rotation map, and weight history stay right where they are. You get one continuous record across both medications, so you can see the whole arc — semaglutide and tirzepatide — in a single timeline. See the full feature set here.
Because the app stores everything on-device with no account, no cloud, and no servers, there is nothing to migrate and no sign-in to recover. Your history is simply on your phone, before and after the switch. If you are also moving away from another tracker as part of this transition, our guide on how to switch GLP-1 tracker apps explains why starting sooner preserves more of your data, and our best Mounjaro tracker app comparison covers what to look for in a tirzepatide-ready tracker. You can also explore the dedicated tirzepatide tracker page for how the dual-mechanism schedule is handled.
Frequently Asked Questions
Do I start Mounjaro at the dose equal to my Ozempic dose?
No. There is no equivalent dose between semaglutide and tirzepatide — they are different molecules on different milligram scales. The standard approach is to start Mounjaro at 2.5 mg, but your prescriber sets your exact starting dose and schedule.
Will I lose my weight-loss progress by restarting titration?
Usually not. The 2.5 mg lead-in is a non-therapeutic starting step, but tirzepatide's dual mechanism means many people keep seeing results during the early weeks. Track week by week and discuss your trend with your prescriber.
How long until I'm on a higher Mounjaro dose?
Each step typically lasts about four weeks before a possible increase, but the pace is individualized. Your prescriber may move faster or slower depending on side effects and response, so confirm your timeline with them rather than assuming a fixed schedule.
Can I switch back to Ozempic later?
That is a clinical decision for your prescriber. People do move between GLP-1 medications for tolerability, coverage, or results reasons. If you do, the same principle applies — you don't carry milligrams across, and titration is set by your prescriber.
Does my injection-site rotation reset when I switch?
No. Both drugs use the same subcutaneous sites, so keep your existing rotation pattern going. In OffGrid Dose your site-rotation map carries straight through the medication change without resetting.
This article is for general educational purposes only and is not medical advice. Dosing, switching decisions, and titration timing must be made by your prescriber based on your individual health. Always verify your exact dose and schedule with the clinician who wrote your prescription, and never adjust your medication on your own.
Related Articles